Alex Berenson Quotes

The goal of re-importation is to provide American consumers with access to drugs at the world market price - not the inflated price now paid only by Americans.

It's time to stop defending a system that is clearly in dire need of reform, stop issuing reports and setting up new roadblocks, and start providing Americans with prescription drugs that are both safe and affordable.

Reducing the price of cancer drugs is a humanitarian move.

EpiPen is not unique. It falls into a category of old drugs, many of which should have long been subject to generic competition.

I think we can build broad bipartisan support for bringing down prescription drug costs.

While American taxes pay for much of the research and development that goes into creating the new, life-saving drugs, American consumers continue to subsidize the cost of the drugs for consumers across the world.

The rising cost of prescription drugs has sparked a prairie fire that is spreading across our nation.

I've always considered making it legal for Americans to import their prescription drugs a free-trade issue. Imports create competition and keep domestic industry more responsive to consumers.

While I recognize the great value and importance of prescription drugs and strongly support a continued U.S. focus on pharmaceutical research and development, our nation's seniors cannot be asked to subsidize the drug costs of other wealthy industrialized nations any longer.

When a company owns a drug, it has a responsibility to make sure that the drug is available to all who need it.

We took away government’s power to bring down the price of drugs using its buying power. Nonetheless, the Affordable Health Care Act is a great step forward.

Price gouging for drugs that treat cancer in children is simply unconscionable.

I want to make sure that our bio-similars capture a huge market share and help cancer patients around the world, which we are already doing in the developing world because we didn't have access to these drugs. Biocon enjoys a large reputation of giving them high-quality cancer drug.

President Trump has exposed the dirty secret of drug pricing: There is a shadowy third player in the transaction between patients and their pharmacists: middlemen who have taken a big kickback from the drug manufacturer, which may or may not be reflected in patients' out-of-pocket costs.

Competition is the best way to ensure prescription drugs are affordable.

I don't like protecting pharmaceutical industries and increasing their profits and making our drugs cost more. If the U.S. Democrats could get rid of those problems I'd be much happier.

As a doctor, my thing is, we need to have access to medications; we need to have reasonable prices for medications.

How long do we have to keep fighting for affordable prescription drugs?

Today the biggest problem in caring for those with AIDS is no longer mainly a medical or scientific problem. The crisis is access to affordable drugs.

We've had a long wrangle with the pharmaceutical industry about parallel imports, and what we were saying is we want to make medicines and drugs as affordable as a possible to what is largely a poor population.

When I first sat down with my oncologist the day before Thanksgiving, and she told me I would need 8 rounds of chemo, one of my first questions admittedly was: 'Will I lose my hair?' It sounds shallow, I know, but it was a very scary image to me.

Patients are becoming aware that they're being taken for a ride by big pharma companies. They charge high prices and have never cared for India's healthcare. There are 23 million cases of cancer every year and India has a fair share of that.

The United States government approaches patient choice in medication as Singapore does free speech: its pronouncements sound reasonable and tolerant until you threaten its prerogatives.

We must take action now, by permitting re-importation, to ensure that health care and prescription drugs remain accessible and affordable for everyone.

To get discounts on some drugs, private insurers are willing to pay top prices for blockbuster pharmaceuticals like Vioxx, despite the fact that Vioxx was rumored to cause fatal strokes and heart attacks.